Investors Cool On Seagen As Merck & Co Merger Hopes Fade

Seagen Suggests Focus On Own M&A

 
• By Andrew McConaghie
  
Seagen
Merck has said to have cooled off because of Seagen's asking price - but a deal might still be struck. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business